Nyxoah to Participate in the Stifel 2025 Healthcare ConferenceNyxoah to Participate in the Stifel 2025 Healthcare Conference
Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® SystemNyxoah Announces First U.S. Commercial Patients Implanted with Genio® System
Nyxoah Provides an Update on Expanded Middle East PresenceNyxoah Provides an Update on Expanded Middle East Presence
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
Nyxoah Announces Upcoming Investor EventsNyxoah Announces Upcoming Investor Events
Nyxoah Announces Preliminary Results for the Second Quarter of 2025Nyxoah Announces Preliminary Results for the Second Quarter of 2025
Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep MedicineNyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
Nyxoah to Present at the Jefferies Global Healthcare ConferenceNyxoah to Present at the Jefferies Global Healthcare Conference
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025
Conditional Issuance of SharesINSIDE INFORMATIONREGULATED INFORMATION
Nyxoah Provides Update on FDA Approvable Letter for Genio SystemNyxoah Provides Update on FDA Approvable Letter for Genio System Expects to meet final FDA requirements for full PMA approval in the second quarter
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceNyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle EastNyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle EastFirst patient implanted with Genio at Saudi German Hospital in Dubai, United Arab Emirates
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in EnglandNyxoah Announces Commercial Launch of Genio® Innovative Therapy in EnglandFirst patients implanted with Genio at UCLH, London
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nyxoah Appoints John Landry as Chief Financial OfficerNyxoah Appoints John Landry as Chief Financial Officer
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational UpdateDREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Nyxoah to Participate in Upcoming Investor ConferencesNyxoah to Participate in Upcoming Investor Conferences
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea DeviceNyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024
Nyxoah Appoints Scott Holstine as Chief Commercial OfficerNyxoah Appoints Scott Holstine as Chief Commercial Officer
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDANyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA
Nyxoah to Participate in the Jefferies Global Healthcare ConferenceNyxoah to Participate in the Jefferies Global Healthcare Conference
Nyxoah Announces Pricing of OfferingREGULATED INFORMATIONINSIDE INFORMATION
Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024
Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery FoundationNyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery FoundationFirst medical device company to become a corporate champion at the ENTerprise Circle level
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary EndpointsNyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
